Sort
15,842 grants matching “pancreatic cancer”
Elucidating KRAS-specific vulnerabilities in pancreatic cancer
$37,557Mandar Deepak Muzumdar · Dana-Farber Cancer Inst · K08 · FY2017 · CA
In-vivo characterization of pancreatic field carcinogenesis using spatially resolved reflectance measurements via a fiber optic probe
$37,544Adam Eshein · Northwestern University · F31 · FY2016 · EB
Elucidating Kras-driven immune infiltration and function in pancreatic cancer
$37,520Ashley Velez · University Of Michigan At Ann Arbor · F31 · FY2020 · CA
Metabolic interactions in the pancreatic tumor microenvironment
$37,520Samuel Andrew Kerk · University Of Michigan At Ann Arbor · F31 · FY2020 · CA
Cancer Therapeutics Program (CRX)
$37,510Craig Lee Slingluff · University Of Virginia · P30 · FY2020 · CA
Cancer Therapeutics Program (CRX)
$37,510Craig Lee Slingluff · University Of Virginia · P30 · FY2021 · CA
Screening for antagonists of nuclear receptor LRH-1 in pancreatic cancer cells
$37,466Robert J Fletterick · University Of California, San Francisco · R03 · FY2013 · MH
Genetics, Epigenetics and Metabolism Research Program
$37,440Paula M Vertino · University Of Rochester · P30 · FY2025 · CA
Stem cell signals in pancreatic adenocarcinoma metastasis and therapy resistance
$37,437Nikki Katherine Lytle · University Of California, San Diego · F31 · FY2016 · CA
The role of IDO and Th17 in an experimental mouse model of glioma
$37,411Derek Alan Wainwright · University Of Chicago · F32 · FY2012 · NS
Divergent response to radio-immunotherapy in HNSCC and PDAC is mediated by regulatory T cells
$37,384Jacob Gadwa · University Of Colorado Denver · F31 · FY2024 · DE
Targeting pyrimidine biosynthesis in pancreatic ductal adenocarcinoma
$37,354Nicholas James Mullen · University Of Nebraska Medical Center · F30 · FY2022 · CA
Elucidating Kras-driven immune infiltration and function in pancreatic cancer
$37,318Ashley Velez · University Of Michigan At Ann Arbor · F31 · FY2021 · CA
Exploring the role of stromal GLI proteins in Pancreatic Ductal Adenocarcinoma
$37,270Michael Kemper Scales · University Of Michigan At Ann Arbor · F31 · FY2020 · CA
Design and Development of a Small Molecule-controlled Activator of RAS
$37,250John Christopher Rose · University Of Washington · F30 · FY2014 · CA
Mechanisms of Lymphatic Metastasis in Pancreatic Ductal Adenocarcinoma
$37,226Benjamin Michael Kahn · University Of Pennsylvania · F30 · FY2025 · CA
Quantitative Oncology
$37,226Paul T Spellman · Oregon Health & Science University · P30 · FY2020 · CA
Real Time Metabolic Imaging to Interrogate Early Detection and Prevention of Pancreatic Cancer
$37,180Jose S Enriquez · University Of Tx Md Anderson Can Ctr · F99 · FY2023 · CA
The role of MIRO2 in tumor cell invasion and metastasis
$37,154Dillon Boulton · University Of Colorado Denver · F31 · FY2023 · CA
Metabolism of Extracellular Matrix Supports Pancreatic Cancer Growth
$37,153Peter Kim · University Of Michigan At Ann Arbor · F31 · FY2019 · CA
Immunology/Immunotherapy Program - IMM
$37,027Victor H. Engelhard · University Of Virginia · P30 · FY2019 · CA
Elucidating the functional role of Camk2b loss in pancreatic cancer metastasis
$37,023Jessica Peura · Univ Of Massachusetts Med Sch Worcester · F31 · FY2025 · CA
Defining a Molecularly Distinct Subtype of Non Small Cell Lung Cancer
$37,020Alexander Augustyn · Ut Southwestern Medical Center · F30 · FY2015 · CA
Targeting hyaluronan in the tumor microenvironment to improve DNA vaccine immunotherapy
$37,004Elizabeth Kennedy Duperret · Wistar Institute · F32 · FY2018 · CA
The Role of HIF2 in Pancreatic Ductal Adenocarcinoma
$37,001Albert Koong · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA